Kestra Medical Technologies, Ltd.
KMTS
$24.83
-$0.38-1.51%
NASDAQ
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.49% | 12.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.49% | 12.41% | |||
| Cost of Revenue | 5.90% | 9.58% | |||
| Gross Profit | 29.07% | 15.96% | |||
| SG&A Expenses | 13.56% | -33.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.58% | -26.28% | |||
| Operating Income | -9.96% | 40.10% | |||
| Income Before Tax | -26.98% | 49.43% | |||
| Income Tax Expenses | 3.03% | -67.65% | |||
| Earnings from Continuing Operations | -26.95% | 49.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.95% | 50.39% | |||
| EBIT | -9.96% | 40.10% | |||
| EBITDA | -9.43% | 42.10% | |||
| EPS Basic | -26.76% | 77.64% | |||
| Normalized Basic EPS | -26.80% | 76.47% | |||
| EPS Diluted | -26.76% | 77.64% | |||
| Normalized Diluted EPS | -26.80% | 76.47% | |||
| Average Basic Shares Outstanding | 0.14% | 108.69% | |||
| Average Diluted Shares Outstanding | 0.14% | 108.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||